Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Duong CN et al. | 2016 | intact cell/cell culture, HMO6 cells (human microglial cell line) | magnetic field, low frequency, 50/60 Hz, co-exposure | 0.01–1 mT |
Feng B et al. | 2016 | intact cell/cell culture, human amniotic cells | magnetic field, 50/60 Hz | 0.2–2 mT |
Garip AI et al. | 2010 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, low frequency, 50/60 Hz | 1 mT |
Giorgi G et al. | 2014 | intact cell/cell culture, human neuroblastoma cell line (BE(2)C) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Grassi C et al. | 2004 | intact cell/cell culture, human neuroblastoma cell line (IMR 32) and rat pituitary (GH3) cell line | magnetic field, low frequency, 50/60 Hz, co-exposure | 200–500 µT |
Guo H et al. | 2004 | intact cell/cell culture, SNU cells (human gastric adenocarcinoma cell line) | magnetic field, 50/60 Hz | 97 mT |
Han Q et al. | 2018 | - | magnetic field, 50/60 Hz, co-exposure | - |
Hisamitsu T et al. | 1997 | intact cell/cell culture, HL-60 and ML-1 cells (human acute myeloid leukaemia cell lines) and human peripheral blood lymphocytes and human peripheral blood polymorphonuclear cells | magnetic field, 50/60 Hz | 45 mT |
Hosseinabadi MB et al. | 2019 | human | magnetic field, low frequency, 50/60 Hz, occupational | 11.3–18.9 µT |
Hu Y et al. | 2016 | animal, mouse/3xTg and 129/C57BL/6, whole body | magnetic field, 50/60 Hz | 500 µT |
Ismael SJ et al. | 1998 | animal, mouse/Swiss, whole body | magnetic field, static magnetic field, 50/60 Hz, DC | 0.4–20 µT |
Jia HL et al. | 2014 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz, co-exposure | 400 µT |
Jung JH et al. | 2017 | intact cell/cell culture, human mesenchymal stem cells | magnetic field, low frequency, 50/60 Hz | - |
Juszczak K et al. | 2012 | intact cell/cell culture, urothelial cells (primary culture from urinary bladders of female Wistar rats) | magnetic field, signals/pulses, 50/60 Hz, electrotherapy | 45 mT |
Kaszuba-Zwoinska J et al. | 2010 | intact cell/cell culture, U937 (human leukemic monocyte cell line) | magnetic field, signals/pulses, 50/60 Hz, co-exposure | 45 mT |
Kaszuba-Zwoinska J et al. | 2012 | intact cell/cell culture, Mono Mac 6 cells (human monocytes) | magnetic field, signals/pulses, 50/60 Hz, co-exposure | 45 mT |
Kayhan H et al. | 2020 | intact cell/cell culture, human, neonatal, healthy primary dermal fibroblast and MCF7 cells (human metastatic breast cancer cells) | magnetic field, 50/60 Hz, low frequency | - |
Khadir R et al. | 1999 | intact cell/cell culture, neutrophils (from human venous blood) | magnetic field, 50/60 Hz, co-exposure | 0.1–44 mT |
Kim HS et al. | 2014 | animal, mouse/BALB/c, whole body | magnetic field, 50/60 Hz | 2–200 µT |
Kim J et al. | 2010 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line) and IMR90 (human lung fibroblasts) | magnetic field, 50/60 Hz | 3–6 mT |
Kim YW et al. | 2009 | animal, mouse/BALB/c, whole body | magnetic field, 50/60 Hz | 14–200 µT |
Kiray A et al. | 2013 | animal, rat/Wistar, whole body | magnetic field, 50/60 Hz | 3 mT |
Koh EK et al. | 2008 | intact cell/cell culture, different human prostate carcinoma cell lines (DU145, LNCaP, PC3) | magnetic field, 50/60 Hz, power transmission line | 0.2–2.5 mT |
Kroupova J et al. | 2007 | intact cell/cell culture, A549 (human adenocarcinoma cell line) | magnetic field, 50/60 Hz | 2 mT |
Kumlin T et al. | 2002 | animal, mouse/BALB/CŒDBA/2, whole body | magnetic field, 50/60 Hz, co-exposure | 100 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.